Oasis Centre for Reproductive The Info Blog Medicine, a Hyderabad-based in-vitro fertilization (IVF) chain of clinics, said that it had raised $6.2 million (Rs 40 crore) from India Life Sciences Fund II. Founded in 2009 by infertility specialist Durga G Rao and entrepreneur Kiran Gadela, Oasis operates three IVF centers in Hyderabad and Vijayawada. The promoters plan to use the funding to open 20 more clinics in Bengaluru, Chennai, and other cities during the next five years.
The healthcare-focused India Life Sciences Fund has made significant investments in other Indian pharmaceutical and healthcare players, including Hyderabad-based Gland Pharma, in the past. For Oasis, this is the first investment from outside.
“Since inception, Oasis’ key focus has been establishing a center of excellence with transparent, ethical, and evidence-based practice to treat infertility. India Life Sciences Fund backing us is further testimony to the quality of service we provide at Oasis. The investment would be used to start 20 more centers in the next five years, primarily focusing on expansion in South India,” said Kiran Gadela, co-founder and managing director at Oasis.
The IVF market is predicted to grow at a CAGR of 10.1 percent in the next five years to reach a little over Rs 5,000 crore by 2021, with infertility being a huge unmet need, according to Anula K Jayasuriya, managing director of InvAscent, the investment advisor to EILSF (Evolvence India Life Sciences fund) and India Life Sciences Fund II. Jayasuriya has joined the board of Oasis.
READ ALSO :
- India is Facebook’s top priority, driving engagement to catch up with Google.
- India still impedes FDI in some retail and finance areas, rues USTR.
- Is environment education in India at odds with its development agenda?
- PNB Housing Finance and Varun Beverages join the Indian IPO boom
- Accenture to pay $500,000 to software engineer from India over discrimination in wages
“Oasis, which strongly focuses on research, will also create extensive training programs in clinical and embryology services. We have developed world-class systems, processes, and protocols, and our multi-disciplinary teams work diligently to implement them. This is reflected in our excellent results,” said Oasis cofounder Durga G Rao.
